Cancer Immunotherapy Conference features latest research on response, resistance, treatment | Science Codex

Here & Now
|

Automatic TRANSCRIPT

We've seen spectacular results, including patients who are surviving for decades as a result of these novel treatments. When we look more specifically at the population said, have been treated by the drug that Jim. Team has developed. We can see the twenty percent of those live for at least three years with many patients living ten years and beyond. These are really unprecedented results for patients who really had no other options. James Allison started his career at MD Anderson in nineteen seventy seven. And then he returned in two thousand twelve to work on the MD Anderson moon shots program, which we've talked about before, basically allowing people to work on things that might pan out and might be game changers or maybe they won't how many examples like this? Have you had of the moon shots

Coming up next